Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEBE III: Erythropoietin for left ventricular function after acute myocardial infarction
2006-002940-28Phase 3Active
- Sponsor
- Netherlands Heart Institute
- Start
- Jul 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Epoetin alfa single bolus with Placebo single bolus (2 arms). Primary endpoint: Left ventricular ejection fraction at 4 months. Started Jul 2006; status: active.
02
Drugs
epoetin alfa
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2006-002940-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002940-28.